PUBLISHER: TechNavio | PRODUCT CODE: 2126011
PUBLISHER: TechNavio | PRODUCT CODE: 2126011
Global Cellular Health Screening Market 2026-2030
The global cellular health screening market is forecasted to grow by USD 4400.2 mn during 2025-2030, accelerating at a CAGR of 17.3% during the forecast period. The report on the global cellular health screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing global shift toward preventive healthcare and longevity, integration of multi-omics and high-throughput diagnostic panels, rising prevalence of chronic diseases and environmental stressors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 15.7% |
| CAGR | 17.3% |
| Incremental Value | $4400.2 mn |
Technavio's global cellular health screening market is segmented as below:
By Channel
- Office
- Hospital
- Diagnostic labs
- Home
- Others
By Type
- Single test panels
- Multi test panels
By Technology
- qPCR and PCR
- Flow cytometry
- ELISA
- NGS
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expansion of direct-to-consumer at-home collection screening kits as one of the prime reasons driving the global cellular health screening market growth during the next few years. Also, incorporation of ai into cellular multi-omic analytics and integration of cellular screening into corporate wellness programs will lead to sizable demand in the market.
The report on the global cellular health screening market covers the following areas:
- Global cellular health screening market sizing
- Global cellular health screening market forecast
- Global cellular health screening market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cellular health screening market vendors that include Agilent Technologies Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Cell Science Systems Corp., Creative Bioarray, Epimorphy LLC, Fagron Genomics S.L.U., Fulgent Genetics Inc., Genova Diagnostics Inc., Laboratory Holdings Inc., Life Length SL, Macrogen Inc., NutriPATH Pty Ltd, Quest Diagnostics Inc., Repeat Diagnostics Inc., Sonic Healthcare Ltd., SpectraCell Laboratories Inc., SYNLAB International GmbH, TeloNostiX Ltd, TruDiagnostic LLC. Also, the global cellular health screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Cellular Health Screening Market 2020 - 2024
- Historic Market Size - Data Table on Global Cellular Health Screening Market 2020 - 2024 ($ million)
- 5.2 Channel segment analysis 2020 - 2024
- Historic Market Size - Channel Segment 2020 - 2024 ($ million)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global cellular health screening market
- 6.2 Impact of geopolitical conflicts on global cellular health screening market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Channel
- 8.1 Market segments
- 8.2 Comparison by Channel
- 8.3 Office - Market size and forecast 2025-2030
- 8.4 Hospital - Market size and forecast 2025-2030
- 8.5 Diagnostic labs - Market size and forecast 2025-2030
- 8.6 Home - Market size and forecast 2025-2030
- 8.7 Others - Market size and forecast 2025-2030
- 8.8 Market opportunity by Channel
- Market opportunity by Channel ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Single test panels - Market size and forecast 2025-2030
- 9.4 Multi test panels - Market size and forecast 2025-2030
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- 10.2 Comparison by Technology
- 10.3 qPCR and PCR - Market size and forecast 2025-2030
- 10.4 Flow cytometry - Market size and forecast 2025-2030
- 10.5 ELISA - Market size and forecast 2025-2030
- 10.6 NGS - Market size and forecast 2025-2030
- 10.7 Others - Market size and forecast 2025-2030
- 10.8 Market opportunity by Technology
- Market opportunity by Technology ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Argentina - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growing global shift toward preventive healthcare and longevity
- Integration of multi-omics and high-throughput diagnostic panels
- Rising prevalence of chronic diseases and environmental stressors
- 13.2 Market challenges
- Complex regulatory validation pathways and diagnostic standardization deficits
- Biological sample degradation and cold chain logistics constraints
- Data privacy vulnerabilities and consumer trust deficits
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Expansion of direct-to-consumer at-home collection screening kits
- Incorporation of AI into cellular multi-omic analytics
- Integration of cellular screening into corporate wellness programs
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.5 ARUP Laboratories
- ARUP Laboratories - Overview
- ARUP Laboratories - Product / Service
- ARUP Laboratories - Key offerings
- SWOT
- 15.6 BGI Genomics Co. Ltd.
- BGI Genomics Co. Ltd. - Overview
- BGI Genomics Co. Ltd. - Product / Service
- BGI Genomics Co. Ltd. - Key offerings
- SWOT
- 15.7 Cell Science Systems Corp.
- Cell Science Systems Corp. - Overview
- Cell Science Systems Corp. - Product / Service
- Cell Science Systems Corp. - Key offerings
- SWOT
- 15.8 Creative Bioarray
- Creative Bioarray - Overview
- Creative Bioarray - Product / Service
- Creative Bioarray - Key offerings
- SWOT
- 15.9 Fulgent Genetics Inc.
- Fulgent Genetics Inc. - Overview
- Fulgent Genetics Inc. - Product / Service
- Fulgent Genetics Inc. - Key offerings
- SWOT
- 15.10 Genova Diagnostics Inc.
- Genova Diagnostics Inc. - Overview
- Genova Diagnostics Inc. - Product / Service
- Genova Diagnostics Inc. - Key offerings
- SWOT
- 15.11 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
- 15.12 Life Length SL
- Life Length SL - Overview
- Life Length SL - Product / Service
- Life Length SL - Key offerings
- SWOT
- 15.13 Macrogen Inc.
- Macrogen Inc. - Overview
- Macrogen Inc. - Product / Service
- Macrogen Inc. - Key offerings
- SWOT
- 15.14 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
- 15.15 Sonic Healthcare Ltd.
- Sonic Healthcare Ltd. - Overview
- Sonic Healthcare Ltd. - Business segments
- Sonic Healthcare Ltd. - Key offerings
- Sonic Healthcare Ltd. - Segment focus
- SWOT
- 15.16 SpectraCell Laboratories Inc.
- SpectraCell Laboratories Inc. - Overview
- SpectraCell Laboratories Inc. - Product / Service
- SpectraCell Laboratories Inc. - Key offerings
- SWOT
- 15.17 SYNLAB International GmbH
- SYNLAB International GmbH - Overview
- SYNLAB International GmbH - Product / Service
- SYNLAB International GmbH - Key offerings
- SWOT
- 15.18 TruDiagnostic LLC
- TruDiagnostic LLC - Overview
- TruDiagnostic LLC - Product / Service
- TruDiagnostic LLC - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
